blonanserin has been researched along with ketamine in 1 studies
Studies (blonanserin) | Trials (blonanserin) | Recent Studies (post-2010) (blonanserin) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
---|---|---|---|---|---|
121 | 21 | 93 | 15,029 | 2,321 | 6,678 |
Protein | Taxonomy | blonanserin (IC50) | ketamine (IC50) |
---|---|---|---|
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enomoto, T; Ikeda, K; Ikejiri, M; Iwamura, Y; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Nakayama, T; Ogi, Y | 1 |
1 other study(ies) available for blonanserin and ketamine
Article | Year |
---|---|
The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Callithrix; Cognition Disorders; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Executive Function; Female; Ketamine; Male; Mental Recall; Oxazines; Piperazines; Piperidines | 2016 |